Andrew Leggett
Motley Fool analyst who covers healthcare and medical-technology stocks, providing the episode's detailed analysis and investment case for Nanosonics and its Trophon disinfection system.
Best podcasts with Andrew Leggett
Ranked by the Snipd community
Nov 24, 2021 • 23min
Stock of the Week: Nanosonics (ASX:NAN), November 24, 2021
Andrew Leggett, a Motley Fool analyst covering healthcare and med-tech, discusses Nanosonics and its Trophon high-level disinfection system. He explains how the device cleans ultrasound probes and why probe sterilisation matters for preventing hospital infections. Conversation covers Trophon adoption, the razor-and-blade consumables model, pandemic effects on sales, market position and competition, and regulatory and concentration risks.
